Lilly Alzheimer’s Drug Helped Patients in Small Trial

1 points by albertwang 5 years ago | 2 comments

albertwang 5 years ago |

Donanemab slowed cognitive and functional decline of patients with mild Alzheimer’s by 32% compared with placebo

waynekerr 5 years ago |

now that is good news....

albertwang 5 years ago |

Donanemab slowed cognitive and functional decline of patients with mild Alzheimer’s by 32% compared with placebo

waynekerr 5 years ago |

now that is good news....